Whalegun
Home

David Kirn, CEO: 4D Molecular Therapeutics FDMT Sell · Filed 24/01/08

Trade details

Type
Insider sale
Amount
$827,266.92
Shares · price
40,732 sh · $20.31 a share
Held after
1,185,087 sh
Stock
4D Molecular Therapeutics FDMT
Person
David KirnCEO
Trade date
24/01/04
Filed
24/01/08
Days to filing
4 days

Sold 3.3% of holdings

Share of holding sold
3.3%

4D Molecular Therapeutics trades, last 26 weeks

What else happened in 4D Molecular Therapeutics around then

Filed or reported within 30 days of the trade day · 23/12/05~24/02/03

David Kirn's recent trades

  • David Kirn

    Planned sale10b5-1 plan4D Molecular Therapeutics

    $802.7K

    Filed 09/14

  • David Kirn

    Planned sale10b5-1 plan4D Molecular Therapeutics

    $1.2M

    Filed 08/19

  • David Kirn

    Planned sale10b5-1 plan4D Molecular Therapeutics

    $275.4K

    Filed 08/04

  • David Kirn

    Planned sale10b5-1 plan4D Molecular Therapeutics

    $125.3K

    Filed 08/03

  • David Kirn

    Planned sale10b5-1 plan4D Molecular Therapeutics

    $193.6K

    Filed 07/10

David Kirn, CEO — sold $827.3K of 4D Molecular Therapeutics FDMT · 3.3% of holdings · 10b5-1 plan | Whalegun